Aroa Biosurgery

(ASX) ARX

Current PriceA$0.65

Market CapA$224.56M

Since IPO (2020)-52%

5 Year-40%

1 Year+30%

1 Month+5%

Aroa Biosurgery Financials at a Glance

Market Cap

A$224.56M

Revenue (TTM)

A$133.18M

Net Income (TTM)

A$3.49M

EPS (TTM)

A$0.01

P/E Ratio

56.52

Dividend

A$0.00

Beta (Volatility)

0.06 (Low)

Dividend

A$0.00

Beta (Volatility)

0.06 (Low)

Price

A$0.65

Volume

180,699

Open

A$0.61

Price

A$0.65

Volume

180,699

Open

A$0.61

Previous Close

A$0.65

Daily Range

A$0.61 - A$0.66

52-Week Range

A$0.46 - A$0.80

Estimated Earnings Date

Nov 24, 2026

Dividend

A$0.00

Beta (Volatility)

0.06 (Low)

Price

A$0.65

Volume

180,699

Open

A$0.61

Previous Close

A$0.65

Daily Range

A$0.61 - A$0.66

52-Week Range

A$0.46 - A$0.80

Estimated Earnings Date

Nov 24, 2026

ARX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aroa Biosurgery

Industry

Biotechnology

Sector

Health Care

CEO

Brian Roderick Ward, PhD, MBA

Website

www.aroa.com

Headquarters

Auckland, 2022, NZ

ARX Financials

Key Financial Metrics (TTM)

Gross Margin

86%

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

1.77%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$224.56M

Shares Outstanding

345.47M

Volume

180.70K

Avg. Volume

186.93K

Financials (TTM)

Gross Profit

A$79.63M

Operating Income

A$4.36M

EBITDA

A$9.03M

Operating Cash Flow

A$9.37M

Capital Expenditure

-A$985.46K

Free Cash Flow

A$8.39M

Cash & ST Invst.

A$22.60M

Total Debt

A$5.31M

Aroa Biosurgery Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

A$50.82M

+182.5%

Gross Profit

A$43.92M

+181.3%

Gross Margin

86.42%

N/A

Market Cap

A$224.56M

N/A

Market Cap/Employee

A$822.55K

N/A

Employees

273

N/A

Net Income

A$5.15M

+440.4%

EBITDA

A$8.12M

+645.1%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

A$22.60M

+12.3%

Total Debt

A$5.31M

-16.0%

Accounts Receivable

A$33.84M

+40.7%

Inventory

A$5.01M

-40.6%

Long Term Debt

A$4.08M

-25.6%

Short Term Debt

A$1.23M

-26.7%

Return on Assets

3.47%

N/A

Return on Invested Capital

6.84%

N/A

Free Cash Flow

A$4.94M

+267.2%

Operating Cash Flow

A$5.44M

+343.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MVF.AXMonash IVF Group Limited

MVF.AXMonash IVF Group LimitedA$0.69+2.24%

OCC.AXOrthocell Limited

OCC.AXOrthocell LimitedA$0.74-1.34%

AVH.AXAVITA Medical, Inc.

AVH.AXAVITA Medical, Inc.A$1.08-5.68%

TTX.AXTetratherix Ltd.

TTX.AXTetratherix Ltd.A$6.00+14.29%

AFP.AXAFT Pharmaceuticals Limited

AFP.AXAFT Pharmaceuticals LimitedA$3.07-5.54%

SOM.AXSomnoMed Limited

SOM.AXSomnoMed LimitedA$0.53-9.48%

DXB.AXDimerix Limited

DXB.AXDimerix LimitedA$0.17-2.94%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

INTCIntel

INTCIntel$124.57+0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About ARX

What is the current price of Aroa Biosurgery?

Aroa Biosurgery is trading at A$0.65 per share.

What is the 52-week range for Aroa Biosurgery?

Over the past 52 weeks, Aroa Biosurgery has traded between A$0.46 and A$0.80.

How much debt does Aroa Biosurgery have?

As of the most recent reporting period, Aroa Biosurgery reported total debt of A$5.31M.

How much cash does Aroa Biosurgery have on hand?

Aroa Biosurgery reported A$17.54M in cash and cash equivalents in its most recent financial results.

What is Aroa Biosurgery’s dividend yield?

Aroa Biosurgery does not currently have a dividend yield.

Aroa Biosurgery

Aroa Biosurgery Financials at a Glance

ARX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aroa Biosurgery

ARX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aroa Biosurgery Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ARX

What is the current price of Aroa Biosurgery?

What is the 52-week range for Aroa Biosurgery?

How much debt does Aroa Biosurgery have?

How much cash does Aroa Biosurgery have on hand?

What is Aroa Biosurgery’s dividend yield?

Premium Investing Services